Working with the Port Authority of New York and New Jersey on Site Selection to Expand Testing to Other Locations
Announces Brand Launch of XpresCheck, Which Will Operate Under Company’s XpresTest SubsidiaryNEW YORK, May 22, 2020 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today provided a business update related to its objective of pursuing COVID-19 screening and testing in convenient and accessible locations at U.S. airports.The Company is pleased to announce that it has signed a contract with JFK International Air Terminal LLC (“JFKIAT”) to pilot test its concept of providing diagnostic COVID-19 tests located in Terminal 4. To facilitate the JFK pilot test, the Company has signed an agreement with JFKIAT for a new modular

Read More At Article Source | Article Attribution